Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
about
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain.Three-month paliperidone palmitate - a new treatment option for schizophrenia.Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics.Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal.Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.Systematic review of pharmacoeconomic models for schizophrenia
P2860
Q38649630-1423354E-94B9-42E3-B98D-F737E9DC3AE0Q38692993-CDA4A1D2-D8AF-4319-B7AF-5C567D6E5AD6Q38840088-6630DE92-1B0C-4C35-BF2C-D5767F92535FQ39537859-4D712D6D-50DC-499C-86B8-C33985368387Q47225222-0E67F8B3-A4D0-4137-8773-CFC62F58439FQ48179219-71B584FC-C66E-4DF7-94C5-AD942DAECF19Q52800015-60F7100A-1A69-4D73-BC87-07ACDC178E75Q55443557-085335E9-1D47-4C30-82CE-50F2B2C8960FQ57169493-EBD14E82-A767-435F-B976-9D30BD92F358
P2860
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@ast
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@en
type
label
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@ast
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@en
prefLabel
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@ast
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@en
P2093
P2860
P1433
P1476
Cost Effectiveness of Paliperi ...... nt of Schizophrenia in France.
@en
P2093
Agathe Doutriaux
Annabelle Godet
Magali Cognet
Pascal Guillon
Pierre Levy
Sylvain Druais
P2860
P2888
P304
P356
10.1007/S40273-015-0348-X
P577
2016-02-16T00:00:00Z